44th Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Annual Lynn Sage Breast Cancer Symposium

Lynn Sage Breast Cancer Symposium has been called the most valuable breast cancer meeting worldwide for the practicing clinician. For over 20 years, this multidisciplinary CME event has been bringing together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer. New options are occurring in all aspects of patient care including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, novel biologic therapies as well as survivorship. This symposium focuses on the multidisciplinary cooperation that is required for the management of today’s breast cancer patient.

43rd Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Advances in Breast Cancer Research

Make plans to join leading basic, translational, and clinical investigators at the tenth AACR Special Conference on Advances in Breast Cancer Research. This year’s program will once again address basic and translational breast cancer research not typically covered in other breast cancer conferences with a more clinical agenda. Topics will include novel model systems, inflammation and the microenvironment, genomics, heterogeneity, personalized risk and prevention, and future therapies and immuno-oncology.

Annual Lynn Sage Breast Cancer Symposium

Lynn Sage Breast Cancer Symposium has been called the most valuable breast cancer meeting worldwide for the practicing clinician. For over 20 years, this multidisciplinary CME event has been bringing together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer. New options are occurring in all aspects of patient care including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, novel biologic therapies as well as survivorship. This symposium focuses on the multidisciplinary cooperation that is required for the management of today’s breast cancer patient.

12th European Breast Cancer Conference

The 12th edition of the European Breast Cancer Conference (EBCC-12) will provide a unique multidisciplinary setting for all professionals with a common interest in breast cancer to discuss, debate, inform and educate themselves about this evolving disease landscape.

This international conference is directed towards a broad audience including scientists, clinicians, patient representatives and health professionals of diverse profiles who tackle key issues facing patients throughout the continuum of the breast cancer journey.

42 Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

5th ESO-ESMO Advanced Breast Cancer (ABC5) International Consensus Conference

The International Consensus Conference for Advanced Breast Cancer (ABC) has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of ABC patients. These guidelines are based on the most up-to-date evidence and can be used to guide treatment decision making in many different health care settings globally, with the necessary adaptations due to different access to care.

We believe that health professionals working closely together with patient advocates and with the strong support of media can raise awareness about the needs and challenges faced by this traditionally underserved and forgotten group of patients. ABC also aims to identify research priorities based on the most important areas of unmet need, analyse and discuss available data to provide the most accurate management recommendations, as well as influence policy makers and funding bodies and ultimately improve standards of care, survival and quality of life. Research and education, with accurate usage of available knowledge, throughout the world, are key to achieve these goals.

Komen® Charlotte Metastatic Breast Cancer Conference

Join Susan G. Komen Charlotte for our first-ever Metastatic Breast Cancer Conference. Our goal is to bring together individuals affected by metastatic breast cancer (MBC) with scientific and medical experts to learn about the latest advances in treatment, awareness and availability of clinical trials, increase quality of life, and provide an opportunity for attendees to interact with each other.

The MBC Conference will last approximately five hours, and will include breakfast and lunch, as well as speakers and a professional panel of experts addressing the following topics:

  • The latest advances in MBC treatment/ongoing research.
  • The importance and availability of MBC clinical trials using an expert in this field.
  • Topic related to psychosocial and/or quality of life challenges.

Up ↑